Hindié, E., & Morgat, C. (2019). Early use of abiraterone and radium-223 in metastatic prostate cancer. The lancet oncology, 20(5), e229. https://doi.org/10.1016/S1470-2045(19)30235-9
Citace podle Chicago (17th ed.)Hindié, Elif, a Clément Morgat. "Early Use of Abiraterone and Radium-223 in Metastatic Prostate Cancer." The Lancet Oncology 20, no. 5 (2019): e229. https://doi.org/10.1016/S1470-2045(19)30235-9.
Citace podle MLA (9th ed.)Hindié, Elif, a Clément Morgat. "Early Use of Abiraterone and Radium-223 in Metastatic Prostate Cancer." The Lancet Oncology, vol. 20, no. 5, 2019, p. e229, https://doi.org/10.1016/S1470-2045(19)30235-9.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..